Immunosuppression and carcinogenesis: contrasting effects with 7,12-dimethylbenz[a]anthracene, benz[a]pyrene, and 3-methylcholanthrene.
Ball
J K
JK
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000009:adverse effects*; D000818:Animals; D000831:Animals, Newborn; D000917:Antibody Formation / Q000187:drug effects*; D001564:Benzo(a)pyrene / Q000009:adverse effects*; D002273:Carcinogens / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008223:Lymphoma / Q000139:chemically induced / Q000276:immunology*; D008748:Methylcholanthrene / Q000009:adverse effects*; D051379:Mice; D013953:Thymus Neoplasms / Q000139:chemically induced / Q000276:immunology*; D013997:Time Factors
D002273:Carcinogens; D007166:Immunosuppressive Agents; D001564:Benzo(a)pyrene; D008748:Methylcholanthrene; D015127:9,10-Dimethyl-1,2-benzanthracene